Yannan Zheng1 article listing Yannan Zheng in Nature Communications, indexed by Paperzzz from Crossref and OSF.Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial Nature Communications